Nabriva Therapeutics(NBRVF)
$0.010.00 (0.00%)
NBRVF
Nabriva Therapeutics earnings date
$0.01
At close:0.00 (0.00%)
Nabriva Therapeutics (NBRVF) Q2 2023 Earnings Report
1,010 Followers
NBRVF Q2 2023 EPS Results
- Actual EPS
- ―
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -$0.18
NBRVF Q2 2023 Revenue Results
- Actual Revenue
- ―
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/10/2023
- Time
- TBA
- Conference Call
- Thursday, August 10, 2023
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
NBRVF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 09, 2023 | 2023 (Q3) | ―- | ― | ― | |
| Aug 10, 2023 | 2023 (Q2) | ―- | -0.18 | ― | |
| May 11, 2023 | 2023 (Q1) | ―-2.72 | -5 | 45.64% (+2.28) | |
| Mar 16, 2023 | 2022 (Q4) | -4.03-4.15 | -6 | 30.83% (+1.85) | |
| Nov 10, 2022 | 2022 (Q3) | -4.03-4.21 | -5.25 | 19.81% (+1.04) | |
| Aug 03, 2022 | 2022 (Q2) | -5.00-4.50 | -7.25 | 37.93% (+2.75) | |
| May 05, 2022 | 2022 (Q1) | -4.75-5.00 | -13.25 | 62.26% (+8.25) | |
| Mar 29, 2022 | 2021 (Q4) | -4.75-6.00 | -27.75 | 78.38% (+21.75) | |
| Nov 09, 2021 | 2021 (Q3) | -5.50-5.25 | -22.5 | 76.67% (+17.25) | |
| Aug 05, 2021 | 2021 (Q2) | -8.67-7.25 | -35 | 79.29% (+27.75) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

